Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration

被引：0

作者：

Alexander Egilman

Joshua D. Wallach

Jeremy Puthumana

Audrey D. Zhang

Jason L. Schwartz

Joseph S. Ross

机构：

[1] Yale-New Haven Hospital,Center for Outcomes Research and Evaluation

[2] Yale School of Public Health,Department of Environmental Health Sciences

[3] Yale School of Medicine,Department of Internal Medicine

[4] Duke University School of Medicine,Department of Medicine

[5] Yale School of Public Health,Department of Health Policy and Management

来源：

Journal of General Internal Medicine | 2021年 / 36卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：3281 / 3284

页数：3

共 50 条

[41] Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated Approval
Shahzad, Mahnum
Naci, Huseyin
Wagner, Anita K.
JAMA INTERNAL MEDICINE, 2021, 181 (12) : 1673 - 1675
[42] Oncology Drug Development and Approval of Systemic Anticancer Therapy by the US Food and Drug Administration
Martell, Robert E.
Sermer, David
Getz, Kenneth
Kaitin, Kenneth I.
ONCOLOGIST, 2013, 18 (01): : 104 - 111
[43] Comparison of Oncology Drug Approval Between Health Canada and the US Food and Drug Administration
Ezeife, Doreen A.
Truong, Tony H.
Heng, Daniel Y. C.
Bourque, Sylvie
Welch, Stephen A.
Tang, Patricia A.
CANCER, 2015, 121 (10) : 1688 - 1693
[44] Food and drug administration approval status
Jöechle, W
JOURNAL OF EQUINE VETERINARY SCIENCE, 2004, 24 (09) : 366 - 366
[45] Biota announces US Food and Drug Administration approval for Relenza® for the treatment of influenza
不详
AUSTRALASIAN BIOTECHNOLOGY, 1999, 9 (03) : 139 - 140
[46] Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab Crisis or Opportunity?
Crosson, Francis J.
Covinsky, Kenneth
Redberg, Rita F.
JAMA INTERNAL MEDICINE, 2021, 181 (10) : 1278 - 1280
[47] Vaccines, pharmaceutical products, and bioterrorism: Challenges for the US Food and Drug Administration
Zoon, KC
EMERGING INFECTIOUS DISEASES, 1999, 5 (04) : 534 - 536
[48] The Next Chapter of Renal Denervation After US Food and Drug Administration Approval
Vongpatanasin, Wanpen
Addo, Tayo
CIRCULATION, 2024, 149 (10) : 760 - 763
[49] Analysis of US Food and Drug Administration Breast Implant Postapproval Studies Finding an Increased Risk of Diseases and Cancer Why the Conclusions Are Unreliable
Swanson, Eric
ANNALS OF PLASTIC SURGERY, 2019, 82 (03) : 253 - 254
[50] Characteristics of race/ethnicity in trials leading to anti-rheumatic drug approval for inflammatory arthritis by the US Food and Drug Administration
Xie, Yan
Liu, Yang
Qin, Yunhe
Chen, Xiaoyuan
Xie, Qibing
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (12) : 2489 - 2497

← 1 2 3 4 5 →